Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-07
4:30 pm
Sale
13DAkoya Biosciences, Inc.
AKYA
Hudson Executive Capital LP1,892,204
4.99%
-555,354decrease
(-22.69%)
View
2022-12-02
4:15 pm
Sale
13DAkoya Biosciences, Inc.
AKYA
Hudson Executive Capital LP2,447,558
6.4%
-1,250,000decrease
(-33.81%)
View
2022-09-13
4:10 pm
Purchase
13DAkoya Biosciences, Inc.
AKYA
Hudson Executive Capital LP3,697,558
9.8%
1,617,015increase
(+77.72%)
View
2022-02-25
10:57 am
Unchanged
13GAkoya Biosciences, Inc.
AKYA
PSC Capital Partners LLC2,813,771
7.6%
0
(Unchanged)
View
2022-02-14
4:44 pm
Unchanged
13GAkoya Biosciences, Inc.
AKYA
Telegraph Hill Partners III, L.P.15,675,247
42.1%
0
(Unchanged)
View
2021-10-18
4:02 pm
Purchase
13DAkoya Biosciences, Inc.
AKYA
Hudson Executive Capital LP2,080,543
5.6%
2,080,543increase
(New Position)
View
2021-05-28
4:01 pm
Purchase
13GAkoya Biosciences, Inc.
AKYA
Telegraph Hill Partners III, L.P.15,675,247
42.7%
15,675,247increase
(New Position)
View